Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Sponsoring organization no longer desired to recruit/maintain registry
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Staunton Farm Foundation | UNKNOWN |
| Elsie H. Hillman Foundation | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
The goal of this observational research registry is to learn about health, wellbeing, and needs of survivors of young adult cancer (diagnosed between the ages of 18 and 39). The main question[s] it aims to understand are:
With this registry, the investigators also plan to identify survivors who may be eligible for participation in future research studies pertaining to young adult cancer.
Participants will be asked to complete electronic surveys every 6 to 12 months during participation in the registry.
The study will be conducted online.
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Anxiety | General Anxiety Disorder-7 (GAD-7). Scores range from 0-21 with higher scores indicating higher levels of anxiety. | enrollment in registry, 6 months later, yearly until death |
| Depressive symptoms | Patient Health Questionnaire- 9 (PHQ-9) Scores range from 0-27, with higher scores indicating more depressive symptoms. | enrollment in registry, 6 months later, yearly until death |
| Social Support | MOS Social Support Survey Instrument The survey consists of four separate social support subscales and an overall functional social support index. A higher score for an individual scale or for the overall support index indicates more support. MOS Social Support Survey Instrument Measure of Social Support Survey Instrument | enrollment in registry, 6 months later, yearly until death |
| Financial Toxicity | COST: A FACIT Measure of Financial Toxicity (COST - FACIT (Ver 2)) Scores range from 0-44. The higher the score, the better the Financial Well-Being | enrollment in registry, 6 months later, yearly until death |
| Needs Assessment | AYA Psycho-Oncology Screening Tool (AYA-POST) There is no scoring required for this tool. | enrollment in registry |
| Measure | Description | Time Frame |
|---|---|---|
| Name, address, email, phone number | Contact information if willing to be alerted about future research | enrollment in registry |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Any young adult diagnosed with cancer between the ages of 18 and 39 willing to register on the YASU website and consents to participation in the research registry.
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Young Adult Survivors United | Wexford | Pennsylvania | 15090 | United States |
Not provided
Starting once enrollment has been open for 6 months.
In order to be granted access to our dataset, the outside researcher would need to secure IRB approval for their proposed study and then would sign a YASU-provided confidentiality agreement.
Datasets shared with researchers outside of YASU will not include identifiers.
Future research collaborators outside of YASU may use the registry to contact participants for other studies and may have access to screen for candidates. Outside researchers who wish to use contacts from the YASU research registry in recruitment for their study will be required to secure IRB approval for their proposed study and to complete the YASU-provided confidentiality agreement prior to any possible participant contact information being shared. Once IRB-approval has been received and the agreement is completed, the PI (and/or YASU executive director) may grant the requestor access to the requested information.
Not provided
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP | Yes | Yes | No | Study Protocol and Statistical Analysis Plan | Jan 16, 2024 | Oct 2, 2025 | Prot_SAP_000.pdf |
Not provided
| ID | Term |
|---|---|
| D009369 | Neoplasms |
| D007938 | Leukemia |
| D012509 | Sarcoma |
| D009373 | Neoplasms, Germ Cell and Embryonal |
| D008223 | Lymphoma |
| D015179 | Colorectal Neoplasms |
| D008545 | Melanoma |
| D001943 | Breast Neoplasms |
| ID | Term |
|---|---|
| D009370 | Neoplasms by Histologic Type |
| D006402 | Hematologic Diseases |
| D006425 | Hemic and Lymphatic Diseases |
| D018204 | Neoplasms, Connective and Soft Tissue |
Not provided
Not provided
Not provided
Not provided
Not provided
| D008232 | Lymphoproliferative Disorders |
| D008206 | Lymphatic Diseases |
| D007160 | Immunoproliferative Disorders |
| D007154 | Immune System Diseases |
| D007414 | Intestinal Neoplasms |
| D005770 | Gastrointestinal Neoplasms |
| D004067 | Digestive System Neoplasms |
| D009371 | Neoplasms by Site |
| D004066 | Digestive System Diseases |
| D005767 | Gastrointestinal Diseases |
| D003108 | Colonic Diseases |
| D007410 | Intestinal Diseases |
| D012002 | Rectal Diseases |
| D018358 | Neuroendocrine Tumors |
| D017599 | Neuroectodermal Tumors |
| D009380 | Neoplasms, Nerve Tissue |
| D018326 | Nevi and Melanomas |
| D012878 | Skin Neoplasms |
| D012871 | Skin Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D001941 | Breast Diseases |